These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22982181)

  • 21. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
    Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
    Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.
    Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S
    Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
    Miao L; Jiao C; Shao R; Qi Y; Fan G; Li X; Wang Y; Zhu Y; Zhang J; Gao X
    Toxicol Appl Pharmacol; 2019 Oct; 381():114637. PubMed ID: 31238046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.
    Nair HB; Kirma NB; Ganapathy M; Vadlamudi RK; Tekmal RR
    Steroids; 2011 Jul; 76(8):792-6. PubMed ID: 21477609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
    Fan S; Liao Y; Qiu W; Li L; Li D; Cao X; Ai B
    Clin Transl Oncol; 2020 Nov; 22(11):2074-2086. PubMed ID: 32367494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
    Abrhale T; Brodie A; Sabnis G; Macedo L; Tian C; Yue B; Serrero G
    BMC Cancer; 2011 Jun; 11():231. PubMed ID: 21658239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
    Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
    Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
    Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
    Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.
    Hershberger PA; Stabile LP; Kanterewicz B; Rothstein ME; Gubish CT; Land S; Shuai Y; Siegfried JM; Nichols M
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):102-9. PubMed ID: 19460433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
    Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
    Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
    Motomura K; Ishitobi M; Komoike Y; Koyama H; Nagase H; Inaji H; Noguchi S
    Oncology; 2010; 79(1-2):55-61. PubMed ID: 21071990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oestrogen receptor β in NSCLC - prevalence, proliferative influence, prognostic impact and smoking.
    Karlsson C; Helenius G; Fernandes O; Karlsson MG
    APMIS; 2012 Jun; 120(6):451-8. PubMed ID: 22583357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
    Tang H; Liao Y; Zhang C; Chen G; Xu L; Liu Z; Fu S; Yu L; Zhou S
    Oncol Res; 2014; 22(1):13-20. PubMed ID: 25700354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
    Stabile LP; Rothstein ME; Cunningham DE; Land SR; Dacic S; Keohavong P; Siegfried JM
    Carcinogenesis; 2012 Nov; 33(11):2181-9. PubMed ID: 22859269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.
    Tang H; Liao Y; Chen G; Xu L; Zhang C; Ju S; Zhou S
    Med Oncol; 2012 Dec; 29(4):2640-8. PubMed ID: 22427208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
    Morandi A; Martin LA; Gao Q; Pancholi S; Mackay A; Robertson D; Zvelebil M; Dowsett M; Plaza-Menacho I; Isacke CM
    Cancer Res; 2013 Jun; 73(12):3783-95. PubMed ID: 23650283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoexpression of aromatase and estrogen receptors β in stem spermatogonia of bullfrogs indicates a role of estrogen in the seasonal spermatogonial mitotic activity.
    Caneguim BH; da Luz JS; Valentini SR; Cerri PS; Sasso-Cerri E
    Gen Comp Endocrinol; 2013 Feb; 182():65-72. PubMed ID: 23247274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?
    Thornton MJ; Nelson LD; Taylor AH; Birch MP; Laing I; Messenger AG
    J Invest Dermatol; 2006 Sep; 126(9):2010-8. PubMed ID: 16691199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.